Covid-19: US agency launches raft of clinical trials of treatments for long covid

The US National Institutes of Health (NIH) has announced a series of clinical trials of possible treatments for long covid, a problem that affects several million Americans.1 At least 11 potential treatments will be studied in the coming months with phase 2 clinical trials of at least four possible treatments set to start immediately.The Department of Health and Human Services also announced a new Office of Long Covid Research and Practice to lead the long covid response and coordination throughout the federal government.2The government has been criticised by some doctors and patient groups for being slow to tackle the problem of long covid.Treatments to be evaluated include drugs, biologics, medical devices, and other therapies. The trials will focus on several of the symptoms patients describe as most burdensome. Trials will investigate multiple treatments simultaneously to identify effective therapies more quickly.The treatments will be studied through Recover, a large, nationwide research…
Read Original Article: Covid-19: US agency launches raft of clinical trials of treatments for long covid »